American National Bank & Trust’s Exelixis EXEL Stock Holding History

American National Bank & Trust’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7	Closed	-$153	–	590
2023 Q3	$153	Hold	7	–	–	﹤0.01%	586
2023 Q2	$134	Hold	7	–	–	﹤0.01%	570
2023 Q1	$136	Hold	7	–	–	﹤0.01%	563
2022 Q4	$1K	Buy	+7	New	+$114	﹤0.01%	540

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

American National Bank & Trust's EXEL Position: Q4 2023 in Review

American National Bank & Trust sold out of Exelixis (EXEL) in Q4 2023, closing a stake of 7 shares — an estimated $153 sold.

American National Bank & Trust first reported a position in EXEL in Q4 2022 and held it in 4 quarters. The position peaked at $1K in Q4 2022. 425 funds tracked by Wall St. Rank hold EXEL as of Q4 2023.

American National Bank & Trust reported no remaining Exelixis position as of Q4 2023 after selling out during the quarter.
American National Bank & Trust sold 7 Exelixis shares in Q4 2023, an estimated $153.
American National Bank & Trust first reported a position in Exelixis in Q4 2022 and held it in 4 quarters.
American National Bank & Trust's Exelixis position peaked at $1K in Q4 2022.
425 funds tracked by Wall St. Rank held Exelixis as of Q4 2023.

Based on American National Bank & Trust's 13F filing for Q4 2023, filed 8 Feb 2024.